Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:930-934
Published online before print October 25, 2004, doi: 10.1161/01.HYP.0000147823.50497.a9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/6/930    most recent
01.HYP.0000147823.50497.a9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Harst, P.
Right arrow Articles by van Gilst, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Harst, P.
Right arrow Articles by van Gilst, W. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Bypass Surgery
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Risk Factors
Right arrow CV surgery: coronary artery disease
Right arrow Other Vascular biology

(Hypertension. 2004;44:930.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Vascular Response to Angiotensin II Predicts Long-Term Prognosis in Patients Undergoing Coronary Artery Bypass Grafting

Pim van der Harst; Meint Volbeda; Adriaan A. Voors; Hendrik Buikema; Sven Wassmann; Michael Böhm; Georg Nickenig; Wiek H. van Gilst

From the Department of Cardiology (P.v.d.H., M.V., A.A.V.), University Hospital Groningen and the Department of Clinical Pharmacology (H.B., W.H.v.G.), University of Groningen, The Netherlands; and Klinik für Innere Medizin III (S.W., M.B., G.N.), Universitat des Saarlandes, 66424 Homburg, Germany.

Correspondence to Dr W.H. van Gilst, University of Groningen, Faculty of Medical Sciences, Department of Clinical Pharmacology, A. Deusinglaan 1 9713 AV Groningen, The Netherlands. E-mail w.h.van.gilst{at}med.rug.nl

Persistent activation of the renin-angiotensin system leads to downregulation of the angiotensin type-1 receptor, and consequently, to a decreased response to exogenous angiotensin II. In the present study, we investigated the association of angiotensin II responsiveness to clinical outcome after coronary artery bypass grafting (CABG). We studied the responsiveness to exogenous angiotensin II in human thoracic artery preparations of 114 CABG patients. Mean duration of follow-up was 7.3±0.1 years, during which 21 patients experienced a cardiovascular event. A diminished response to angiotensin II remained in multivariate Cox regression analysis, after adjustment for sex, age, blood pressure, and number of diseased coronary arteries, the strongest predictor for cardiovascular events (relative risk, 3.37 [95% confidence interval, 1.20 to 9.51]; P=0.022). Furthermore, diminished response to angiotensin II was associated with an increased mean arterial pressure (102.85±1.38 versus 97.40±1.37; P=0.003) and a nonsignificant increase in angiotensin-converting enzyme activity, suggestive for a persistently activated renin-angiotensin system. In conclusion, these results suggest that in patients undergoing CABG, a diminished vascular responsiveness of the thoracic artery to exogenous angiotensin II is related to an increased risk of future cardiovascular events.


Key Words: angiotensin II • resistance • vasoconstriction • risk factors • coronary artery disease




This article has been cited by other articles:


Home page
HypertensionHome page
H. Oeseburg, D. Iusuf, P. van der Harst, W. H. van Gilst, R. H. Henning, and A. J.M. Roks
Bradykinin Protects Against Oxidative Stress-Induced Endothelial Cell Senescence
Hypertension, February 1, 2009; 53(2): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
L. S.M. Wong, R. A. de Boer, N. J. Samani, D. J. van Veldhuisen, and P. van der Harst
Telomere biology in heart failure
Eur J Heart Fail, November 1, 2008; 10(11): 1049 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Ozaydin, O. Peker, D. Erdogan, S. Kapan, Y. Turker, E. Varol, F. Ozguner, A. Dogan, and E. Ibrisim
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study
Eur. Heart J., March 1, 2008; 29(5): 625 - 631.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. van der Harst, T. D.J. Smilde, H. Buikema, A. A. Voors, G. Navis, D. J. van Veldhuisen, and W. H. van Gilst
Vascular Function and Mild Renal Impairment in Stable Coronary Artery Disease
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 379 - 384.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. A Voors, P. P. van Geel, H. Buikema, M. Oosterga, D. J van Veldhuisen, and W. H van Gilst
High Angiotensin II Responsiveness is Associated with Decreased Endothelium-Dependent Relaxation in Human Arteries
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 145 - 150.
[Abstract] [PDF]